Otonomy's ear disease drug fails key trial, shares nosedive

(Reuters) - U.S. drugmaker Otonomy Inc said on Wednesday it would stop developing its drug to treat Meniere's disease, a chronic, progressive disorder of the inner ear, after it failed a late-stage trial.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news